Terms: = Colorectal cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
35 results:
1. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
Poliani L; Greco L; Barile M; Dal Buono A; Bianchi P; Basso G; Giatti V; Genuardi M; Malesci A; Laghi L;
ESMO Open; 2022 Dec; 7(6):100607. PubMed ID: 36356413
[TBL] [Abstract] [Full Text] [Related]
2. Aldehyde Dehydrogenase 1B1 Is Implicated in DNA Damage Response in Human colorectal Adenocarcinoma.
Tsochantaridis I; Kontopoulos A; Voulgaridou GP; Tsifintaris M; Triantafyllou C; Pappa A
Cells; 2022 Jun; 11(13):. PubMed ID: 35805102
[TBL] [Abstract] [Full Text] [Related]
3. Validation of Genetic Markers Associated with Survival in colorectal cancer Patients Treated with Oxaliplatin-Based Chemotherapy.
Park HA; Seibold P; Edelmann D; Benner A; Canzian F; Alwers E; Jansen L; Schneider M; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):352-361. PubMed ID: 34862210
[TBL] [Abstract] [Full Text] [Related]
4. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
[TBL] [Abstract] [Full Text] [Related]
5. Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
Martin-Morales L; Rofes P; Diaz-Rubio E; Llovet P; Lorca V; Bando I; Perez-Segura P; de la Hoya M; Garre P; Garcia-Barberan V; Caldes T
PLoS One; 2018; 13(9):e0203885. PubMed ID: 30256826
[TBL] [Abstract] [Full Text] [Related]
6. Nucleotide Excision Repair Capacity and xpc and XPD Gene Polymorphism Modulate colorectal cancer Risk.
Mucha B; Pytel D; Markiewicz L; Cuchra M; Szymczak I; Przybylowska-Sygut K; Dziki A; Majsterek I; Dziki L
Clin Colorectal Cancer; 2018 Jun; 17(2):e435-e441. PubMed ID: 29793654
[TBL] [Abstract] [Full Text] [Related]
7. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates colorectal Carcinogenesis and Prognosis.
Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
[TBL] [Abstract] [Full Text] [Related]
8. Exposure to meat-derived carcinogens and bulky DNA adduct levels in normal-appearing colon mucosa.
Ho V; Brunetti V; Peacock S; Massey TE; Godschalk RWL; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
Mutat Res Genet Toxicol Environ Mutagen; 2017 Sep; 821():5-12. PubMed ID: 28735743
[TBL] [Abstract] [Full Text] [Related]
9. Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.
Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
PLoS One; 2016; 11(7):e0159904. PubMed ID: 27467592
[TBL] [Abstract] [Full Text] [Related]
10. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Evidence for xpc-KRAS Interactions During Lung cancer Development.
Zhang X; He N; Gu D; Wickliffe J; Salazar J; Boldogh I; Xie J
J Genet Genomics; 2015 Oct; 42(10):589-596. PubMed ID: 26554912
[TBL] [Abstract] [Full Text] [Related]
12. Lack of associations between xpc polymorphisms and colorectal cancer: a meta-analysis.
Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
[TBL] [Abstract] [Full Text] [Related]
13. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ; Seibold P; Richter S; Scherer D; Habermann N; Balavarca Y; Jansen L; Becker N; Pfütze K; Popanda O; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
Pharmacogenomics J; 2015 Dec; 15(6):505-12. PubMed ID: 25778469
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract] [Full Text] [Related]
15. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract] [Full Text] [Related]
16. xpc Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
[TBL] [Abstract] [Full Text] [Related]
17. CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.
Gil J; Gaj P; Misiak B; Ostrowski J; Karpinski P; Jarczyńska A; Kielan W; Sasiadek MM
Med Oncol; 2014 Jul; 31(7):72. PubMed ID: 24939416
[TBL] [Abstract] [Full Text] [Related]
18. Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.
Steck SE; Butler LM; Keku T; Antwi S; Galanko J; Sandler RS; Hu JJ
Mutat Res; 2014 Apr; 762():24-31. PubMed ID: 24607854
[TBL] [Abstract] [Full Text] [Related]
19. Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.
Chen C; Wang L; Liao Q; Xu L; Huang Y; Zhang C; Ye H; Xu X; Ye M; Duan S
Genet Test Mol Biomarkers; 2014 Mar; 18(3):187-95. PubMed ID: 24552298
[TBL] [Abstract] [Full Text] [Related]
20. xpc Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
[TBL] [Abstract] [Full Text] [Related]
[Next]
